1. Home
  2. SNGX vs JTAI Comparison

SNGX vs JTAI Comparison

Compare SNGX & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.45

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Logo Jet.AI Inc.

JTAI

Jet.AI Inc.

HOLD

Current Price

$0.73

Market Cap

4.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
JTAI
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.8M
4.6M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
SNGX
JTAI
Price
$1.45
$0.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$11.00
AVG Volume (30 Days)
454.0K
1.0M
Earning Date
11-07-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,584,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$433.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$0.67
52 Week High
$6.23
$11.77

Technical Indicators

Market Signals
Indicator
SNGX
JTAI
Relative Strength Index (RSI) 50.04 22.41
Support Level $1.31 $1.06
Resistance Level $1.70 $1.66
Average True Range (ATR) 0.12 0.18
MACD -0.01 -0.04
Stochastic Oscillator 54.55 6.48

Price Performance

Historical Comparison
SNGX
JTAI

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.

Share on Social Networks: